Are you between 18 and 65 years old and being treated for depression? Even if your symptoms have improved, you may still be at risk for them coming back. You may be able to take part in a research study exploring a potential new treatment option.
Depression Study
Age Range:
18 to 65
Gender:
Male and Female
Location:
Media, Pennsylvania
About the Study
This research study is looking at an investigational medication called brenipatide, which is being studied alongside your current antidepressant treatment. The goal is to learn whether it may help delay or prevent the return of depression symptoms.
Participants will continue taking their current prescribed antidepressant and will receive either the study medication or a placebo (a treatment with no active medication). Study doctors will closely monitor your health, symptoms, and overall well-being throughout the study.
Qualifications
You may be able to join if you:
- Are 18 to 65 years old
- Have been diagnosed with depression (Major Depressive Disorder)
- Are currently feeling better, but still have some remaining symptoms
- Have experienced depression more than once in your life
- Are taking an antidepressant and are willing to stay on your current treatment during the study
FEATURED STUDIES
Heart Failure Prevention Study
Researchers are evaluating an investigational treatment for adults who have type 2 diabetes and cardiovascular disease and may be at
Weight & Wellness Research Study Interest
Researchers are evaluating an investigational oral treatment for adults who are overweight and may be at risk of developing certain
Flu Prevention Study Interest List
Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of
General Anxiety Disorder Study
Individuals with generalized anxiety disorder (GAD) who experience ongoing worry, stress, or difficulty managing anxiety symptoms may qualify for a
Uncontrolled COPD Study
Individuals with chronic obstructive pulmonary disease (COPD) who continue to experience symptoms or flare-ups despite treatment may qualify for a
MDD Study
Adults 18 to 65 years of age with Major Depressive Disorder (MDD) may qualify for a clinical research study evaluating